SSTR2 and neuroendocrine neoplasm: PET imaging of CCK-2 overexpression has presented clinical utility in diagnosing neuroendocrine tumors (NETs) with low somatostatin-2 receptor expression, particularly for the staging of medullary thyroid carcinoma.